Founded in 1993, Pacific Horizon Ventures operates with a hands-on, capital efficient strategy, targeting companies that address significant healthcare problems in underserved markets. With a national presence, they provide just-in-time general management to a select number of portfolio companies, aiming for high financial returns. Their investments are primarily in the biotechnology, pharmaceutical chemistry, medical devices, computational biology, and genomics sectors.